| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24842175d6fd31b867805aa6e77d3b40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ca0c1cf1b7ce700d5fd2ea0b052e83b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fdaa64756184e715af6cb25ebc318917
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d634281b44679b3ced75cfeabbe1f145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6764f05a0538233251ff8eb1366b2dca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7291cb2057e396f6275672b31837e51d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-522 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- |
| filingDate |
2004-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79f79886e4bc255a8cc79c858275fa84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e3b098cef6649e2a488a145a561d8db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e467dba66b85508d143eafa2a7ddb8a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14c6fbfbed5ecc193e6a21bad302b01e |
| publicationDate |
2005-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2005009333-A2 |
| titleOfInvention |
Combined treatments comprising synthetic peptide copolymers for preventing graft rejection |
| abstract |
The present invention provides compositions and methods for the treatment of graft rejection associated with transplantation of tissues and organs. More specifically, the compositions and methods of the present invention relate to combined treatment involving at least one agent selected from Copolymer 1, a copolymer 1-related heteropolymer or an ordered peptide in combination with at least one additional known immunosuppressive agent. The present invention also provides compositions and methods for the treatment of graft rejection using ordered peptides or ordered copolymer 1-related heteropolymers as monotherapy. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE49251-E
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11471421-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11167003-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109689082-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009115634-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9200114-B2 |
| priorityDate |
2003-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |